Abstract
Chronic kidney disease-mineral bone disorders (CKD-MBD) are associated with increased risk of fracture. Studies report about 3% of fractures in CKD patients, and these occur earlier than in the general population, namely 16 and 13 years earlier for men and women, respectively. Better understanding of the pathophysiology of fractures would probably contribute to new therapeutic approaches. This study aimed to evaluate report of long bone fractures from a bone biopsies bank from patients on hemodialysis and compare clinical and biochemical characteristics, as well as the results of the histomorphometric analysis of trabecular and cortical bone of these patients with a control group (without fractures), paired for age, gender, and time on hemodialysis. Bone proteins (SOST, DMP1 and MEPE) were evaluated by immunohistochemistry. Seventeen patients with fracture and controls were studied. Fracture prevalence was 0.82/1000 patients/year. Serum phosphorus levels were significantly lower in the fracture group. Histomorphometric analysis revealed that all the patients had high turnover disease, and the fracture group had smaller volume and trabecular thickness, greater osteoid surface, smaller eroded surface, smaller mineralizing surface, formation rate and longer mineralization lag time when compared to controls; the DMP1 expression in the cortical bone was smaller and the SOST in the trabecular bone was higher in fractured patients. As conclusion, we found low prevalence of fractures. Both groups had high turnover disease, but the fractured ones presented more impaired bone microarchitecture, as well as lower formation and greater mineralization defect. Bone proteins expression correlated with parameters involved in bone remodeling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:S131–S139
Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348
Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in United States, 2005–2025. J Bone Miner Res 22:465–475
Coco M, Rush H (2000) Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121
De Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039–1045
Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP (2008) Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate: an improved method for immunohistochemistry. J Bone Miner Metab 26:110–113
Graciolli FG, Neves KR, Barreto F, Barreto DV, dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moyses RMA (2017) The complexity of chronic disease-mineral and bone across stages of chronic kidney disease. Kidney Int 91:1436–1446
Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for Bone Histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17
Dos Reis LM, Batalha JR, Muñoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V (2007) Brazilian normal static bone histomorphometry: effects of age, sex and race. J Bone Miner Metab 25:400–406
Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529–534
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953
Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173
Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859
Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalhães LP, Antunes GL, Custódio MR, Montenegro FL, Titan SM, Jorgetti V, Moysés RM (2013) Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One 8:e68870
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59
Miller PD (2014) Chronic kidney disease and osteoporosis: evaluation and management. Bonekey Rep 3:542
Chappard D, Bizot D, Mabilleau G, Hubert L (2016) Aluminum and bone: review of new circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie 100:95–105
Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC (2016) Bone loss in chronic kidney disease: quantity or Quality? Bone 6:57–70
McNerny EMB, Nickolas TL (2017) Bone quality in chronic kidney disease: definitions and diagnosis. Curr Osteoporos Rep 15:207–213
Barger-Lux MJ, Recker RR (2002) Bone microstructure in osteoporosis: transilial biopsy and histomorphometry. Top Magn Reson Imaging 13:297–306
Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB (2017) Fractures and osteomalacia in a patient treated with frequent home hemodialysis. Am J Kidney Dis 70:445–448
Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161–1168
Suzuki S, Haruyama N, Nishimura F, Kulkarni AB (2012) Dentin sialophosphoprotein and dentin matrix protein-1: two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol 57:1165–1175
Winkler DG, Sutherland MK, Georghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22:6267–6276
Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695–705
Acknowledgements
This study was presented, in part, at the 2017 World Congress of Nephrology in Mexico City, Mexico. The results presented in this paper have not been published previously in whole or part, except in abstract format. The authors thank Rosimeire A. B. Costa for the technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Rosa M. A. Moysés, Vanda Jorgetti and Aluizio B. Carvalho have received lecture fees and are consultant to Sanofi, Abbott do Brasil, and Amgen. All other authors have no conflict of interest.
About this article
Cite this article
Santos, M.F.P., Hernández, M.J., de Oliveira, I.B. et al. Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures. J Bone Miner Metab 37, 125–133 (2019). https://doi.org/10.1007/s00774-018-0902-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-018-0902-7